Nichols & Pratt Advisers LLP Gilead Sciences, Inc. Transaction History

Nichols & Pratt Advisers LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 24, 2020	SELL	$62.63 - $80.22 $2.86 Million - $3.67 Million	-45,700 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$61.62 - $67.78 $2.33 Million - $2.56 Million	-37,750 Reduced 45.24%	45,700 $2.97 Million
Q3 2019 Nov 07, 2019	SELL	$62.51 - $69.0 $80,200 - $88,527	-1,283 Reduced 1.51%	83,450 $5.29 Million
Q2 2019 Aug 05, 2019	SELL	$61.87 - $69.38 $414,962 - $465,331	-6,707 Reduced 7.33%	84,733 $5.73 Million
Q1 2019 Apr 30, 2019	SELL	$62.53 - $70.05 $3.18 Million - $3.57 Million	-50,921 Reduced 35.77%	91,440 $5.95 Million
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $448,964 - $585,864	-7,416 Reduced 4.95%	142,361 $8.92 Million
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $163,231 - $180,726	-2,290 Reduced 1.51%	149,777 $11.6 Million
Q2 2018 Jul 27, 2018	SELL	$64.88 - $75.68 $174,527 - $203,579	-2,690 Reduced 1.74%	152,067 $10.8 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $18,064 - $22,022	-248 Reduced 0.16%	154,757 $11.6 Million
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $72,573 - $85,190	-1,020 Reduced 0.65%	155,005 $11.1 Million
Q3 2017 Nov 08, 2017	SELL	$72.11 - $85.47 $283,392 - $335,897	-3,930 Reduced 2.46%	156,025 $12.7 Million
Q2 2017 Aug 08, 2017	BUY	N/A	159,955	159,955 $11.3 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Nichols & Pratt Advisers LLP , based on Form 13F filings with the SEC.

Stay updated on Nichols & Pratt Advisers LLP with notifications on news.